142 related articles for article (PubMed ID: 24632547)
1. The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer.
Sakai T; Mashima H; Yamada Y; Goto T; Sato W; Dohmen T; Kamada K; Yoshioka M; Uchinami H; Yamamoto Y; Ohnishi H
Pancreas; 2014 Aug; 43(6):909-16. PubMed ID: 24632547
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury.
Klune JR; Dhupar R; Kimura S; Ueki S; Cardinal J; Nakao A; Nace G; Evankovich J; Murase N; Tsung A; Geller DA
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G666-73. PubMed ID: 22744333
[TBL] [Abstract][Full Text] [Related]
3. An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance.
Shao L; Srivastava R; Delgoffe GM; Thorne SH; Sarkar SN
Cancer Immunol Res; 2024 Jun; 12(6):779-790. PubMed ID: 38517470
[TBL] [Abstract][Full Text] [Related]
4. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 is transcriptionally regulated by SP1, IRF1 and IRF2 in hepatoma cells.
Wang DP; Yu ZX; He ZC; Liao JF; Shen XB; Zhu PL; Chen WN; Lin X; Xu SH
FEBS Lett; 2020 Oct; 594(19):3108-3121. PubMed ID: 32671843
[TBL] [Abstract][Full Text] [Related]
6. Ctenopharyngodon idella IRF2 plays an antagonistic role to IRF1 in transcriptional regulation of IFN and ISG genes.
Gu M; Lin G; Lai Q; Zhong B; Liu Y; Mi Y; Chen H; Wang B; Fan L; Hu C
Dev Comp Immunol; 2015 Mar; 49(1):103-12. PubMed ID: 25463511
[TBL] [Abstract][Full Text] [Related]
7. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
[TBL] [Abstract][Full Text] [Related]
8. HCFC2 is needed for IRF1- and IRF2-dependent
Sun L; Jiang Z; Acosta-Rodriguez VA; Berger M; Du X; Choi JH; Wang J; Wang KW; Kilaru GK; Mohawk JA; Quan J; Scott L; Hildebrand S; Li X; Tang M; Zhan X; Murray AR; La Vine D; Moresco EMY; Takahashi JS; Beutler B
J Exp Med; 2017 Nov; 214(11):3263-3277. PubMed ID: 28970238
[TBL] [Abstract][Full Text] [Related]
9. Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.
Hochhaus A; Yan XH; Willer A; Hehlmann R; Gordon MY; Goldman JM; Melo JV
Leukemia; 1997 Jul; 11(7):933-9. PubMed ID: 9204971
[TBL] [Abstract][Full Text] [Related]
10. Pig conceptuses increase uterine interferon-regulatory factor 1 (IRF1), but restrict expression to stroma through estrogen-induced IRF2 in luminal epithelium.
Joyce MM; Burghardt JR; Burghardt RC; Hooper RN; Jaeger LA; Spencer TE; Bazer FW; Johnson GA
Biol Reprod; 2007 Aug; 77(2):292-302. PubMed ID: 17475929
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Funamizu N; Hu C; Lacy C; Schetter A; Zhang G; He P; Gaedcke J; Ghadimi MB; Ried T; Yfantis HG; Lee DH; Subleski J; Chan T; Weiss JM; Back TC; Yanaga K; Hanna N; Alexander HR; Maitra A; Hussain SP
Int J Cancer; 2013 Feb; 132(4):785-94. PubMed ID: 22821831
[TBL] [Abstract][Full Text] [Related]
12. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer.
Chen Y; Kang M; Lu W; Guo Q; Zhang B; Xie Q; Wu Y
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1463-74. PubMed ID: 22526154
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action.
Köninger J; Giese NA; di Mola FF; Berberat P; Giese T; Esposito I; Bachem MG; Büchler MW; Friess H
Clin Cancer Res; 2004 Jul; 10(14):4776-83. PubMed ID: 15269152
[TBL] [Abstract][Full Text] [Related]
14. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers.
Wang Y; Liu DP; Chen PP; Koeffler HP; Tong XJ; Xie D
Cancer Res; 2007 Mar; 67(6):2535-43. PubMed ID: 17363571
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
[TBL] [Abstract][Full Text] [Related]
16. The role of IRF1 and IRF2 transcription factors in leukaemogenesis.
Choo A; Palladinetti P; Passioura T; Shen S; Lock R; Symonds G; Dolnikov A
Curr Gene Ther; 2006 Oct; 6(5):543-50. PubMed ID: 17073600
[TBL] [Abstract][Full Text] [Related]
17. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
19. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
20. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells.
Jiang PH; Motoo Y; Sawabu N; Minamoto T
World J Gastroenterol; 2006 Mar; 12(10):1597-602. PubMed ID: 16570353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
